Hawkins

Hawkins stock hit a new 52-week low of 117.94 USD after a weekly loss of 9.6%, pushing market capitalization down to 2.48 billion USD. The stock is down about 30.37% year‑over‑year despite a 34-year dividend history. Analyst price targets range from 142 to 200 USD; Barclays rates Hawkins as “Equalweight” with a 170 USD target, citing stable demand in the water treatment sector and a route-based business model. » Więcej na de.investing.com

The board of directors of Hawkins has increased the quarterly cash dividend by 5% to $0.20 per share. The payment date is August 28, 2026, with a record date for shareholders of August 14, 2026. Hawkins has paid uninterrupted dividends since 1985 and generated revenue of about $1.1 billion in fiscal year 2026. » Więcej na de.investing.com

Giverny Capital purchased shares of Hawkins following a brief autumn price correction and after meeting management in summer 2024. Hawkins, a specialty ingredients maker for water treatment, food and industrial uses, closed at $130.25 on Jan. 30, 2026, and has gained about 15.8% over the past year. The fund noted Hawkins is overlooked by many hedge funds but sees potential, while still favoring certain AI stocks for higher upside and lower downside risk. » Więcej na finance.yahoo.com

Hawkins has completed the acquisition of the assets of Redbird Chemical to expand its water treatment business in eastern Texas. Financial details were not disclosed; Redbird serves industrial and water‑treatment customers in the region. Hawkins emphasizes maintaining local business relationships and sees the transaction as complementary to its growth strategy in the southern U.S. The company reported revenue of $974 million for 2025, operates 65 locations and announced a quarterly dividend of $0.19 per share (payable 28 Nov 2025, record date 14 Nov 2025). » Więcej na de.investing.com

Hawkins stock hit a new record high of $185.52, bringing market capitalization to $3.86 billion. The price rose 45.09% over the past year and 71% in the last six months, while data from InvestingPro classify the stock as overvalued at this level but show very strong financial health. Raymond James initiated coverage with a "Market Perform" rating and warned of structurally limited long‑term earnings growth in the low to mid double‑digit percentage range. » Więcej na de.investing.com